Paul Hastings Advised Oppenheimer & Co. as Sole Bookrunner in Vaxart's Underwritten Common Stock Offering
June 15, 2024
June 15, 2024
LOS ANGELES, California, June 15 -- Paul Hastings, a law firm, issued the following news:
Paul Hastings LLP advised Oppenheimer & Co. as the sole bookrunner in connection with Vaxart, Inc.'s (Nasdaq: VXRT) underwritten offering of 50,000,000 shares of its common stock. The offering is expected to close on or about June 17, 2024, subject to customary closing conditions.
Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi led . . .
Paul Hastings LLP advised Oppenheimer & Co. as the sole bookrunner in connection with Vaxart, Inc.'s (Nasdaq: VXRT) underwritten offering of 50,000,000 shares of its common stock. The offering is expected to close on or about June 17, 2024, subject to customary closing conditions.
Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi led . . .